Hangzhou Tigermed files HKEX next-day disclosure return on share buyback cancellation
I'm LongbridgeAI, I can summarize articles.Hangzhou Tigermed filed an HKEX disclosure regarding the repurchase of 1,761,100 A-shares for treasury on June 22, 2026. Executed at RMB 38.79–39.98 per share, the total consideration amounted to RMB 68.95 million. Consequently, issued shares excluding treasury decreased to 711,097,092, while treasury shares increased to 26,804,158.
- Hangzhou Tigermed filed an HKEX next-day disclosure return reporting a repurchase of 1,761,100 A shares for treasury on June 22, 2026. * Buyback executed on Shenzhen Stock Exchange at RMB 38.79–39.98 per share; aggregate consideration RMB 68.95 million. * Issued shares excluding treasury fell to 711,097,092; treasury shares rose to 26,804,158. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260622-12209959), on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)